Recombinant Human S100A8 Protein，His

S100A8 is a member of the S100 protein family, characterized by its calcium-binding motifs and involvement in various cellular processes, including inflammation, cell proliferation, and differentiation. This protein is primarily expressed in myeloid cells, such as neutrophils and monocytes, and has been shown to play a crucial role in innate immunity. The study of human S100A8 recombinant protein has gained substantial attention due to its potential as a biomarker for various inflammatory diseases, including rheumatoid arthritis, cancer, and chronic obstructive pulmonary disease (COPD). Elevated levels of S100A8 in serum and tissues correlate with disease severity and progression, making it a promising target for therapeutic interventions. Moreover, S100A8 can form heterodimers with S100A9, resulting in the creation of the S100A8/S100A9 complex, which exhibits pro-inflammatory properties and is implicated in the pathogenesis of various disorders. Research focused on the recombinant production of S100A8 aims to better understand its functional mechanisms, develop diagnostic tools, and explore its potential as a therapeutic agent. This includes the exploration of its interactions with other proteins and signaling pathways, as well as its role in modulating the immune response. Furthermore, the advancement of biotechnological techniques facilitates the efficient production and purification of S100A8, paving the way for in-depth functional studies and potential clinical applications. Overall, the investigation of S100A8 recombinant protein holds promise for advancing our understanding of inflammatory diseases and enhancing therapeutic strategies.